home / stock / cool:cc / cool:cc news

COOL:CC News and Press, Core One Labs Inc. From 10/14/22

Stock Information
Company Name: Core One Labs Inc.
Stock Symbol: COOL:CC
Market: CNQC
Menu
COOL:CC COOL:CC Quote COOL:CC Short COOL:CC News COOL:CC Articles COOL:CC Message Board
Get COOL:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
COOL:CC - European University to Fund Core One Labs' Akome Advanced Neurogenesis Stimulation Studies

VANCOUVER, BC / ACCESSWIRE / October 14, 2022 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)(WKN:A3CSSU) (the " Company " or " Core One "), further to its press release dated August 18, 2022, is excited to announce its wholly owned subsidiary, Akome Biotech Ltd. (" Akome "),...
COOL:CC - Core One Labs Nearing GMP Production as Canada's Province of Alberta Announces Game Changing Legislation

VANCOUVER, BC / ACCESSWIRE / October 7, 2022 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 )(WKN:A3CSSU) (the " Company " or " Core One "), is pleased to announce that it is nearing good manufacturing practices (GMP) production of its psychedelic compounds, as the Company h...

COOL:CC - Core One Labs Announces Breakthrough with Proprietary Isolation and Purification Method of Psilocybin from Mushrooms; Prepares Patent Application

VANCOUVER, BC / ACCESSWIRE / September 30, 2022 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6) ( WKN: A3CSSU) (the " Company " or " Core One ") is pleased to announce that its wholly-owned subsidiary Awakened Biosciences Inc. (" Awakened ") has developed a groundbreaking ...

COOL:CC - Core One Labs Signs Letter of Intent with GMP Manufacturing Partner for Production of Proprietary Psychedelic Compounds

VANCOUVER, BC / ACCESSWIRE / September 23, 2022 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6 , WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce it has entered into a Letter of Intent (the " LOI ") with Medelys Laboratories International Inc. (" Me...
COOL:CC - Core One Labs' Akome Move Psychedelic Drug Formulations to Next Stage of Development: Initiating Phase 2 Analysis of Therapeutic Potential

VANCOUVER, BC / ACCESSWIRE / September 16, 2022 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6 , WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce that following the receipt of very positive results during phase one (" Phase 1 ") pre-clinical developme...

COOL:CC - Core One Labs' Scientists Successfully Complete Breakthrough First Step in Producing API-Grade DMT

Second Ground Breaking Technological Advancement VANCOUVER, BC / ACCESSWIRE / September 2, 2022 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6)( WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce that scientists at its wholly-owned subsidiary Awa...

COOL:CC - Core One Rolls Out Commercial Sales Strategy for its Revolutionary API Grade Biosynthetic Psilocybin

VANCOUVER, BC / ACCESSWIRE / September 1, 2022 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6 )(WKN: A3CSSU) (the " Company " or " Core One ") announces that it has initiated rollout of its commercial sales strategy for its proprietary biosynthetic API psilocybin product...
COOL:CC - Core One Labs' Akome Achieves Another Milestone in Development of its Psychedelic Drug Formulas and Announces Positive Results from Neuro-Pharmacokinetics Studies

VANCOUVER, BC / ACCESSWIRE / August 19, 2022 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6 , WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (" Akome ") through its formalized research agreement wi...

COOL:CC - Core One Labs' Akome Achieves Significant Research Milestone with Positive Neurogenesis Stimulation Studies Results

Opening the Door to Expanded Patent Coverage VANCOUVER, BC / ACCESSWIRE / August 18, 2022 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6) (WKN:A3CSSU) (the " Company " or " Core One "), further to its press release dated March 4, 2022, is excited to announce its wholly own...

COOL:CC - Core One Labs' Vocan Successfully Converts Psilocin Precursor into Psilocybin

VANCOUVER, BC / ACCESSWIRE / August 16, 2022 / Further to its press release dated August 12, 2022, Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6), (WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce that its wholly-owned subsidiary Vocan Biotechnologi...
Previous 10 Next 10